跳至主要内容
临床试验/JPRN-UMIN000015565
JPRN-UMIN000015565招募中2 期

Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancer - Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancer

Dokkyo Medical University0 个研究点目标入组 22 人开始时间: 2014年10月30日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Symptomatic brain metastasis 2) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 3) With active double cancer or multicentric cancer 4) Treated with radiotherapy within the past four weeks. 5) With clinically important complications. 6) With pleural effusion or pericardial effusion accumulates which need drainage 7) With the history of hypersensitivity for nab-paclitaxel, CBDCA 8) Main organs had a serious medical risk factor, and the physicians judged treatment not to be safe. 9) Physician concludes that the patient's participation in this trial is inappropriate

研究者

相似试验

Phase II study of nab-paclitaxel in combination with... | 临床试验